Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease
April 2013
Signifor (SIG-na-for, pasireotide) is a new option for treating Cushing's disease.
Patients with Cushing's have high corticosteroid levels...leading to central obesity, diabetes, bone loss, etc.
Cushing's DISEASE is due to pituitary tumors...Cushing's SYNDROME is due to adrenal tumors or corticosteroid drug therapy.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote